Education Paves the Way to Entrepreneurial Success

Mark Pieloch is the founder of five highly successful pharmaceutical enterprises that focus on animal health. At a time when many businesses struggle to stay afloat, his current businesses, PF Inc. and PSPC Inc., have not only survived, but also thrived.

In 1975, after graduating seventh in his high school graduating class of 385, Pieloch went on to pursue advanced pharmacy degrees at the Massachusetts College of Pharmacy, graduating magna cum laude. His thesis was based on his research involving the ocular effects of Delta 9 THC for the treatment of glaucoma.

From 1981 to 1983, he began laying the groundwork for his future entrepreneurship by getting a master’s in business administration from the University of Michigan. He majored in Operations Management and International Business, again graduating magna cum laude. After college, Pieloch worked a variety of jobs in the pharmaceutical industry, including work as a pharmacy manager, registered pharmacist and research scientist. In 1985, he began working at SmithKline Beecham Animal Health in various capacities, working his way up to director of the Pharmaceutical Development division. He left SmithKline Beecham in 1990 and started his first business, Pharma Chemie, in Lincoln, Nebraska.

The Pharma Chemie mission was to provide high quality, palatable private label dog, cat and horse nutritional supplements that tasted good and were easy to administer. Pieloch started Pet Flavors (PF Inc.) in 2003, a company dedicated to developing the most palatable flavors to encourage dogs, cats and horses to readily accept medications. He continued his research and in 2007 obtained a U.S. patent for phycocyanin as a treatment for arthritis in non-human mammals. Derived from an extract of blue-green algae, phycocyanin is a proven COX-2 selective agent that relieves arthritis discomfort and reduces inflammation quickly without side effects. This led to his product Phycox Canine Soft Chews (PSPC Inc.) in 2008. Sold to the public only through veterinarians, Phycox is a highly palatable, safe and effective treatment for arthritis in dogs and horses.

Pieloch sold Pharma Chemie in 2012 to concentrate on his core businesses, PF Inc. and PSPC Inc. As other businesses floundered, both PF Inc. and PSPC Inc. prospered. A large part of the success of both businesses comes from his unique skills and background. Pieloch’s education and research skills ensure the continued advancement of the flavor and animal nutritional supplement segments of his businesses. His unflagging dedication to his mission drives him to succeed. Deeply respectful of the emotional bond between humans and their companion animals, Pieloch’s mission has always been to keep the bond strong by finding a way to make it easy to administer medicine and improve a pet’s quality of life. His education and business experience gives him the ability to navigate through recent economic downturns with flexibility and conservative spending.

First and foremost, Mark Pieloch does what he loves. Making the world a better place for pets and their humans using his exceptional research skills is what drives him. As a long time business owner, he knows that the unexpected happens and uses what he has learned over the years to bounce back from adversity. He defines what it means to be an entrepreneur.